Richard Fried
Dermatology · Yardley, PANPI 1801835426
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $22,660 of the $36,507 with a category attached, or 62.1%. It is spread thinly across 37 manufacturers, the largest accounting for just 20.7%. Reporting peaked in 2020 at $10,092 and has fallen 62.7% since, to $3,765 in 2025. Among dermatology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 341 payments — averaging $107.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arcutis Biotherapeutics, Inc.$8K
- UCB, Inc.$7K
- Sun Pharmaceutical Industries Inc.$6K
- Almirall LLC$6K
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$4K
- AbbVie$2K
- plus $6K from 31 others
Across 21 payments — averaging $3984.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$56K
- LEO Pharma AS$21K
- Almirall LLC$6K
- Incyte Corporation$1K
What the payments were for
- Consulting fees$22,66062%
- Speaking & faculty fees$5,20014%
- Travel & lodging$460%
- Food & beverage$8,57623%
- Education$250%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$36,507 in reported general payments places this provider in the 90th percentile of 626 dermatology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 12 | $62,850 |
| Dupixent PenDupilumab | 13 | $62,541 |
| Ivermectin | 66 | $9,039 |
| Pimozide | 83 | $7,737 |
| Fluorouracil | 100 | $5,437 |
| Doxycycline Hyclate | 147 | $3,909 |
| Pimecrolimus | 17 | $2,714 |
| Tacrolimus | 26 | $2,198 |
| Betamethasone Valerate | 19 | $1,368 |
| Minoxidil | 144 | $1,266 |
| Metronidazole | 18 | $1,185 |
| Azelaic Acid | 13 | $1,165 |
| Triamcinolone Acetonide | 62 | $950 |
| Mometasone Furoate | 48 | $662 |
| EryErythromycin Base In Ethanol | 15 | $661 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Yardley
- Adel HaqueYardley$1M
- Scott GottliebExton$2.1M
- Douglas KressWexford$2M
- Stephen HessPhiladelphia$1.7M
- Joel GelfandPhiladelphia$649K
- Neil NirenPittsburgh$574K
- Victoria WerthPhiladelphia$547K
- Mark SeralyMc Murray$545K
- Laura FerrisPittsburgh$502K
- Oleg AkilovPittsburgh$409K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.